Cover Image

Targeting LDL Cholesterol With LNA

Saved in:

Bibliographic Details
Main Author:	Arthur M Krieg (Author)
Format:	Book
Published:	Elsevier, 2012-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond
by: Maya Safarova, et al.
Published: (2024)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
by: Safi U. Khan, et al.
Published: (2020)

Description of Discordance Between LDL Cholesterol, Non-HDL Cholesterol, and LDL Particle Number Among Patients of a Lipid Clinic
by: Joshua W Gaborcik, et al.
Published: (2017)

LDL cholesterol values in a reference mature population
by: Karima Maricel Gondres Legró, et al.
Published: (2016)

Electronic Structures of LNA Phosphorothioate Oligonucleotides
by: Henrik G. Bohr, et al.
Published: (2017)

New and emerging lipid-modifying drugs to lower LDL cholesterol
by: Constantine E Kosmas, et al.
Published: (2021)

Erratum to "Cardiovascular Mortality after Intensive LDL-Cholesterol Lowering: Does Baseline LDL-Cholesterol Really Matter?" [American Journal of Preventive Cardiology 1C (2020) 100013]
by: Safi U. Khan, et al.
Published: (2021)

Dramatic LDL-Cholesterol elevation with Ketogenic Diet: A Case Series
by: David Harmon, et al.
Published: (2020)

Dramatic elevation of LDL cholesterol from ketogenic-dieting: A Case Series
by: Tyler Schmidt, et al.
Published: (2023)

Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review
by: Pınar Kızılırmak, et al.
Published: (2020)

Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study
by: Sergio Cinza-Sanjurjo, et al.
Published: (2024)

Investigating discovery strategies and pharmacological properties of stereodefined phosphorodithioate LNA gapmers
by: Jörg Duschmalé, et al.
Published: (2022)

Inhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors
by: Cathy Staedel, et al.
Published: (2015)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
by: Jelle M. Beernink, et al.
Published: (2022)

Selected Soybean Varieties Regulate Hepatic LDL-Cholesterol Homeostasis Depending on Their Glycinin:β-Conglycinin Ratio
by: Miguel Rebollo-Hernanz, et al.
Published: (2022)

Can Vitamin B12 Assist the Internalization of Antisense LNA Oligonucleotides into Bacteria?
by: Sara Pereira, et al.
Published: (2021)

Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
by: Christeen Samuel, et al.
Published: (2023)

Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials
by: Kyoko Taku, et al.
Published: (2008)

Dyslipidemia in subclinical hypothyroidism requires assessment of small dense low density lipoprotein cholesterol (sdLDL-C)
by: Saric Maida Seferovic, et al.
Published: (2017)

Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice
by: Fatemeh Momen-Heravi, et al.
Published: (2021)

Hydrogel-Assisted Antisense LNA Gapmer Delivery for In Situ Gene Silencing in Spinal Cord Injury
by: Pedro M.D. Moreno, et al.
Published: (2018)

A Mechanistic Systems Pharmacology Model for Prediction of LDL Cholesterol Lowering by PCSK9 Antagonism in Human Dyslipidemic Populations
by: K Gadkar, et al.
Published: (2014)

Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals
by: Punit P Seth, et al.
Published: (2012)

LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation
by: Asad Ali, et al.
Published: (2024)

Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation
by: Massimiliano Fonsi, et al.
Published: (2024)

Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemia?
by: Broekhuizen Karen, et al.
Published: (2012)

Efectos de una intervención educativa sobre los niveles plasmáticos de LDL-colesterol en diabéticos tipo 2 Effects of an educational intervention on plasma levels of LDL cholesterol in type-2 diabetics
by: Carlos Enrique Cabrera-Pivaral, et al.
Published: (2001)

OBICETRAPIB TARGETS ALL ATHEROGENIC LIPOPROTEINS BEYOND LDL-C
by: Michael Davidson, MD
Published: (2024)

Factors Associated With Achievement of Blood Pressure, Low-Density Lipoprotein Cholesterol (LDL-C), and Glycemic Targets for Primary Prevention of Cardiovascular Diseases Among High Cardiovascular Risk Malaysians in Primary Care
by: Noorhida Baharudin, et al.
Published: (2023)

A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa Cells
by: Daniela Castanotto, et al.
Published: (2021)

Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
by: Tsuyoshi Yamamoto, et al.
Published: (2021)

How realistic are the LDL-C targets in new dyslipidemia guidelines - is it possible to reach the targets?
by: Barış Güngör
Published: (2020)

EFFECT OF MANGOSTEEN'S FRUIT PEEL EXTRACT TOWARD TO TOTAL CHOLESTEROL, LDL, HDL SERUM IN RATS WERE GIVEN BY USED COOKING O
by: Loo Hariyanto Raharjo, et al.
Published: (2017)

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
by: Danh Q. Nguyen, et al.
Published: (2024)

Regulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents for lowering blood cholesterol
by: Napatara Tirawanchai, et al.
Published: (2018)

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
by: Maria Eugenia Gallo Cantafio, et al.
Published: (2016)

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
Published: (2016)

Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4' -BNA/LNA with 9-(aminoethoxy)phenoxazine
by: Taiki Matsubayashi, et al.
Published: (2024)

Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine
by: Taiki Matsubayashi, et al.
Published: (2024)

Diterpenoids inhibit ox-LDL-induced foam cell formation in RAW264.7 cells by promoting ABCA1 mediated cholesterol efflux
by: Cheng Zhang, et al.
Published: (2023)